Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Leases Current Taxes Dividends payables Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Growth Metrics

Others

ProPhase Labs (PRPH) Non-Current Deferred Tax Liability (2022)

Historic Non-Current Deferred Tax Liability for ProPhase Labs (PRPH) over the last 1 years, with Q4 2022 value amounting to $224000.0.

ProPhase Labs' Non-Current Deferred Tax Liability changed N/A to $224000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $224000.0, marking a year-over-year change of. This contributed to the annual value of $224000.0 for FY2022, which is N/A changed from last year.
Per ProPhase Labs' latest filing, its Non-Current Deferred Tax Liability stood at $224000.0 for Q4 2022.
ProPhase Labs' Non-Current Deferred Tax Liability's 5-year high stood at $443000.0 during Q1 2022, with a 5-year trough of $224000.0 in Q4 2022.